Document Detail


A quantitative autoradiographic study of serotonin1A receptor regulation. Effect of 5,7-dihydroxytryptamine and antidepressant treatments.
MedLine Citation:
PMID:  2025379     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
There have been few studies investigating the effect of treatments that alter serotonergic neurotransmission on the density of serotonin1A (5-hydroxytryptamine1A [5-HT1A]) receptors, even though lesioning serotonergic neurons has been reported to enhance certain responses thought to be due to activation of 5-HT1A receptors and repeated treatment of rats with different types of antidepressants can diminish 5-HT1A-mediated responses. Consequently, the binding of 3H-8-hydroxy-2-(di-n-propylamino)-tetralin (DPAT) to 5-HT1A receptors in serotonergic cell body and terminal field areas of rat brain was measured by quantitative autoradiography following either the lesioning of serotonergic neurons with 5,7-dihydroxytryptamine (5,7-DHT), or after chronic administration of monoamine oxidase inhibitors (MAOIs) (clorgyline, phenelzine, or tranylcypromine) or inhibitors of 5-HT uptake (citalopram or sertraline). Treatment of rats with 5,7-DHT did not cause any significant increase in binding of 3H-DPAT to 5-HT1A receptors in any area of the brain examined. There was no significant reduction in the binding of 3H-DPAT in terminal field areas of serotonergic innervation in rats treated with 5,7-DHT except in the CA2/CA3 region of the hippocampus (33% to 35% reduction). In the dorsal and median raphe nuclei, the specific binding of 3H-DPAT was reduced by treatment of rats with 5,7-DHT. In lesioned rats, the binding of 3H-cyanoimipramine (3H-CN-IMI) to uptake sites for serotonin was essentially eliminated in all terminal field areas examined, as well as in the dorsal and median raphe nuclei. Repeated administration of clorgyline, phenelzine, tranylcypromine, citalopram, or sertraline produced an attenuation of the hypothermic response of rats to acute subcutaneous injection of the 5-HT1A-receptor-agonist DPAT. In spite of this change in 5-HT1A responsivity, these treatments caused in the same animals no consistent change in the binding of 3H-DPAT in either serotonergic cell body or terminal field areas. Of the five drugs studied that diminished DPAT-induced hypothermia, only phenelzine and clorgyline significantly reduced the binding of 3H-DPAT, and even then in only a few of the 12 areas of brain measured. As a result of treatment of rats with tranylcypromine there was a significant increase in the binding of 3H-DPAT in the CA2/CA3 region of the hippocampus.(ABSTRACT TRUNCATED AT 400 WORDS)
Authors:
J G Hensler; G B Kovachich; A Frazer
Related Documents :
15063159 - Prenatal stress affects 3,4-methylenedioxymethamphetamine pharmacokinetics and drug-ind...
19891989 - Behavioral, thermal and neurochemical effects of acute and chronic 3,4-methylenedioxyme...
9267659 - Inescapable shock-induced potentiation of morphine analgesia in rats: involvement of op...
1687169 - Mdma produces a conditioned place preference and elicits ejaculation in male rats: a mo...
15602749 - 3,4-methylenedioxymethamphetamine counteracts akinesia enantioselectively in rat rotati...
2943219 - 8-oh-dpat-induced hyperphagia: its neural basis and possible therapeutic relevance.
2415679 - Studies on the role of alpha 2-adrenoceptors in the control of synaptosomal [3h]5-hydro...
12845989 - Effects of recombinant platelet activating factor acetylhydrolase in obstructive jaundice.
17430619 - Nociception after intraperitoneal injection of a sodium pentobarbitone formulation with...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology     Volume:  4     ISSN:  0893-133X     ISO Abbreviation:  Neuropsychopharmacology     Publication Date:  1991 Feb 
Date Detail:
Created Date:  1991-06-13     Completed Date:  1991-06-13     Revised Date:  2011-05-18    
Medline Journal Info:
Nlm Unique ID:  8904907     Medline TA:  Neuropsychopharmacology     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  131-44     Citation Subset:  IM    
Affiliation:
Department of Psychiatry and Pharmacology, University of Pennsylvania School of Medicine, Philadelphia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
5,7-Dihydroxytryptamine / metabolism*,  pharmacology
Animals
Antidepressive Agents / metabolism*,  pharmacology
Autoradiography
Brain / drug effects,  metabolism
Depression / metabolism*
Kinetics
Male
Rats
Rats, Inbred Strains
Receptors, Serotonin / metabolism*
Grant Support
ID/Acronym/Agency:
MH 09834/MH/NIMH NIH HHS; MH 14654/MH/NIMH NIH HHS; MH 29024/MH/NIMH NIH HHS
Chemical
Reg. No./Substance:
0/Antidepressive Agents; 0/Receptors, Serotonin; 31363-74-3/5,7-Dihydroxytryptamine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Chronicity of depressive episode in relation to antidepressant-placebo response.
Next Document:  Platelet serotonin uptake in men with family histories of alcoholism.